MSR78 Use of External Control Data to Adjust for Treatment Switching in Cost-Effectiveness Analyses: Lisocabtagene Maraleucel (Liso-Cel) Versus Standard of Care (SOC) in Second-Line Relapsed or Refractory Large B-Cell Lymphoma

Saved in:

Bibliographic Details
Published in	Value in health Vol. 26; no. 12; pp. S407 - S408
Main Authors	Chandler, C., Liu, F.F., Klijn, S., Elsada, A., Proskorovsky, I.
Format	Journal Article
Language	English
Published	01.12.2023
Online Access	Get full text

Loading…

More Information
ISSN:	1098-3015
DOI:	10.1016/j.jval.2023.09.2137